Enright Patrick G
Zenas BioPharma, Inc. · Director
Enright Patrick G is listed in filings as Director at Zenas BioPharma, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including purchase activity. Recent filings connect the profile to Zenas BioPharma, Inc. (ZBIO), Vera Therapeutics, Inc. (VERA), Jazz Pharmaceuticals PLC (JAZZ), and BioAge Labs, Inc. (BIOA). The current snapshot covers public activity from Aug 6, 2024 to May 26, 2026. Reported amounts are shown as $220.9K to $2.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $250k12k shares | BuyOct 9, 2025 | $20.85 | $29.50 | |
| $2M105.3k shares | BuyOct 9, 2025 | $19.00 | $29.50 | |
| $1M69.8k shares | BuyJun 23, 2025 | $20.87 | $39.12 | |
| $303k13.5k shares | BuyJun 24, 2025 | $22.35 | $39.12 | |
| $3M139.6k shares | BuyJun 23, 2025 | $20.87 | $39.12 | |
| $605k27.1k shares | BuyJun 24, 2025 | $22.35 | $39.12 |